Clinical Trial

Time of Oxytocin Initiation at 2nd Stage of Labor and Adverse Outcomes

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 26, 2023 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
Early oxytocin administration at the 2nd stage of labor is associated with a higher rate of vaginal delivery, shorter second stage duration, and fewer adverse maternal and neonatal outcomes.
Trial Details
NCT Number NCT06181396
Lead Sponsor Rambam Health Care Campus
Conditions Delivery Complication, Cesarean Delivery Affecting Fetus
Enrollment 120 participants
Start Date 2023-10-01
Primary Completion 2025-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2023-12-26